Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

NCT03716024 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Infectious Skin Disease
Bacterial Skin Disease

Interventions

DRUG: PTK 0796
DRUG: Linezolid

Sponsor

Paratek Pharmaceuticals Inc